Table 4.
Antibiotic Resistance Patterns of Enterobacteriaceae Isolates
| Antibiotics | Escherichia coli (n:8) | Klebsiella pneumoniae (n:6) | Enterobacter species (n:5) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| S* | I* | R* | S | I | R | S | I | R | |
| Aztreonam | 1 (12.5%) | 2 (25%) | 5 (62.5%) | 2 (33.3%) | 0 | 4 (66.6%) | 5 (100%) | 0 | 0 |
| Cefepime | 3 (37.5%) | 0 | 5 (62.5%) | 3 (50%) | 0 | 3 (50%) | 5 (100%) | 0 | 0 |
| Cefotaxime | 0 | 1 (12.5%) | 7 (87.5%) | 1 (16.7%) | 1 (16.7%) | 4 (66.6%) | 1 (20%) | 1 (20%) | 3 (60%) |
| Ceftazidime | 0 | 1 (12.5%) | 7 (87.5%) | 0 | 1 (16.7%) | 5 (83.3%) | 0 | 1 (20%) | 4 (80%) |
| Ciprofloxacin | 3 (37.5%) | 0 | 5 (62.5%) | 4 (66.6%) | 1 (16.7%) | 1 (16.7%) | 3 (60%) | 2 (40%) | 0 |
| Gentamycin | 5 (62.5%) | 0 | 3 (37.5%) | 4 (66.6%) | 1 (16.7%) | 1 (16.7%) | 5 (100%) | 0 | 0 |
| Imipenem | 5 (62.5%) | 2 (25%) | 1 (12.5%) | 2 (33.3%) | 1 (16.7%) | 3 (50%) | 2 (40%) | 3 (60%) | 0 |
| Meropenem | 0 | 1 (12.5%) | 7 (87.5%) | 0 | 0 | 6 (100%) | 1 (20%) | 0 | 4 (80%) |
| Piperacillin | 1 (12.5%) | 1 (12.5%) | 6 (75%) | 0 | 1 (16.7%) | 5 (83.3%) | 1 (20%) | 1 (20%) | 3 (60%) |
| Piperacillin-Tazobactam | 4 (50%) | 2 (25%) | 2 (25%) | 2 (33.3%) | 2 (33.3%) | 2 (33.3%) | 2 (40%) | 1 (20%) | 2 (40%) |
| Tetracycline | 2 (25%) | 1 (12.5%) | 5 (62.5%) | 3 (50%) | 1 (16.7%) | 2 (33.3%) | 3 (60%) | 1 (20%) | 1 (20%) |
Notes: *S, susceptible; I, intermediate; R, resistant.